Home›Research›Compare›ARA-290 vs Klotho
Peptide ComparisonARA-290 vs Klotho
Both are Longevity & Cellular peptides.
ARA-290
Cibinetide
Half-life: ~2 min (IV); ~10–20 min (SC)
16 providers listed
Klotho carries stronger published evidence (Meta-analysis, 12 key studies) than ARA-290 (RCT, 3); both are research compounds.
ARA-290
Evidence
Half-life
~2 min (IV); ~10–20 min (SC)
Klotho
Evidence
Half-life
—
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Klotho |
| Further along in FDA review | ARA-290 |
| More provider options (16 vs 0) | ARA-290 |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
ARA-290
Klotho
ARA-290
Immunometabolic dysregulation drives selective executive cognitive dysfunction in male db/db mice.
Cibinetide (ARA 290) reduces small nerve fiber pathology in sarcoidosis patients
ARA 290, a non-hematopoietic erythropoietin analogue, improves metabolic control and neuropathic symptoms in…
Klotho
Klotho heterozygosity does not modify cognitive decline in APOE ε4 carriers: analysis of a large biobank coho…
VSIG4 Expression During Renal Aging Is Accelerated by Type 2 Diabetes in Mice.
Gene deletion of Klotho in the dentate gyrus does not affect the number of adult-born granule cells.
Conserved mRNA expression patterns of the Klotho family in canine mammary tumors and human breast cancer.
+8 more
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
About Klotho
Acts as a co-receptor for FGF23, regulating phosphate and vitamin D metabolism. As a circulating hormone, inhibits insulin/IGF-1 signaling to extend lifespan, activates Nrf2 antioxidant pathways, and suppresses TGF-β fibrotic signaling.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
ARA-290
No established clinical contraindications
Klotho
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
ARA-290
Klotho
Not enough vendor pricing yet.
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated July 20, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). ARA-290 vs Klotho — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/ara-290/klotho